A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2025-04-03
DOI
https://doi.org/10.3324/haematol.2024.287053
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma

Susan Kumka, David H. Vesole, Eli Zolotov, David S. Siegel et al.
Haematologica
Multiple Myeloma Research and Treatments
article

A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma

Susan Kumka, David H. Vesole, Eli Zolotov, David S. Siegel, Kimberley Doucette, Harsh Parmar, Palka Anand, Aimee Chappell, Alexandra Della Pia, Noa Biran, Patrick Roney, Joshua Zenreich, Adolfo Aleman, Rena Feinman, Pooja Phull, Jaeil Ahn, Bianca DeAgresta, Monique Pace, E.‐M. Rutanen, Lisa Biamonte
article en

Abstract

No abstract available for this paper.
HaematologicaVol. 110(10)
Hackensack University Medical Center (US), Georgetown University (US), Georgetown University Medical Center (US), Applied Biomathematics (United States) (US), Hackensack Meridian Health (US), Center for Discovery (US)
Karyopharm Therapeutics
Zero hunger
Openalex Percentile: Top 91%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma — Susan Kumka, David H. Vesole, et al. · Haematologica (2025) | TGRS Research Map | TGRS